Form DEFA14A Vigil Neuroscience, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Jefferies Downgrades Vigil Neuroscience Inc (VIGL) to Hold
May 22, 2025 1:19 PM EDTJefferies analyst Andrew Tsai downgraded Vigil Neuroscience Inc (NASDAQ: VIGL) from Buy to Hold with a price target of $8.00 (from $19.00).
The analyst comments "Expected to close in Q3:25, SNY will acquire VIGL for $8/sh (plus a $2/sh CVR). SNY receives VG-3927,... More
